921 related articles for article (PubMed ID: 30551148)
1. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
Semchenko EA; Tan A; Borrow R; Seib KL
Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
[TBL] [Abstract][Full Text] [Related]
2. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
3. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
[TBL] [Abstract][Full Text] [Related]
4. Impact of meningococcal group B OMV vaccines, beyond their brief.
Petousis-Harris H
Hum Vaccin Immunother; 2018 May; 14(5):1058-1063. PubMed ID: 29048985
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of
Petousis-Harris H; Radcliff FJ
Front Immunol; 2019; 10():683. PubMed ID: 31024540
[TBL] [Abstract][Full Text] [Related]
6. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
[TBL] [Abstract][Full Text] [Related]
7. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.
Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM
J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576
[TBL] [Abstract][Full Text] [Related]
8. Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.
Hadad R; Jacobsson S; Pizza M; Rappuoli R; Fredlund H; Olcén P; Unemo M
APMIS; 2012 Sep; 120(9):750-60. PubMed ID: 22882265
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA.
Maritan M; Cozzi R; Lo Surdo P; Veggi D; Bottomley MJ; Malito E
Acta Crystallogr F Struct Biol Commun; 2017 Jun; 73(Pt 6):305-314. PubMed ID: 28580917
[TBL] [Abstract][Full Text] [Related]
10. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
11. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
[TBL] [Abstract][Full Text] [Related]
12. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Findlow J; Borrow R; Snape MD; Dawson T; Holland A; John TM; Evans A; Telford KL; Ypma E; Toneatto D; Oster P; Miller E; Pollard AJ
Clin Infect Dis; 2010 Nov; 51(10):1127-37. PubMed ID: 20954968
[TBL] [Abstract][Full Text] [Related]
14. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
Pajon R; Lujan E; Granoff DM
Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637
[TBL] [Abstract][Full Text] [Related]
15. Conservation of meningococcal antigens in the genus Neisseria.
Muzzi A; Mora M; Pizza M; Rappuoli R; Donati C
mBio; 2013 Jun; 4(3):e00163-13. PubMed ID: 23760461
[TBL] [Abstract][Full Text] [Related]
16. An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.
Thng C; Semchenko EA; Hughes I; O'Sullivan M; Seib KL
BMC Public Health; 2023 Mar; 23(1):607. PubMed ID: 36997957
[TBL] [Abstract][Full Text] [Related]
17. Structure of the Recombinant
Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
[No Abstract] [Full Text] [Related]
18. The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.
Partridge E; Lujan E; Giuntini S; Vu DM; Granoff DM
Vaccine; 2017 Jul; 35(33):4236-4244. PubMed ID: 28651840
[TBL] [Abstract][Full Text] [Related]
19. Neisseria proteomics for antigen discovery and vaccine development.
Christodoulides M
Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
[TBL] [Abstract][Full Text] [Related]
20. Bexsero: a multicomponent vaccine for prevention of meningococcal disease.
Gorringe AR; Pajón R
Hum Vaccin Immunother; 2012 Feb; 8(2):174-83. PubMed ID: 22426368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
